Arterial hypertension, microalbuminuria, and risk of ischemic heart disease

Hypertension

Volumn 35, Issue 4, 2000, Pages 898-903

  Jensen, Jan Skov ^a   Feldt Rasmussen, Bo ^b   Strandgaard, Svend ^b   Schroll, Marianne ^b   Borch Johnsen, Knut ^b  

^a Rigshospitalet   (Denmark)

^b NONE

Author keywords

Arterial; Atherosclerosis; Heart; Hypertension; Ischemia; Microalbuminuria

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0034082720     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.4.898     Document Type: Article

References (54)

1. Parving H-H, Jensen HÆ, Mogensen CE, Evrin P-E. Increased urinary albumin excretion rate in benign essential hypertension. Lancet. 1974;1:1190-1192.
2. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens. 1996;14:223-228.
3. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Clausen P, Appleyard M, Jensen G. Microalbuminuria in arterial hypertension: relation to cardiovascular disease and antihypertensive agents. J Hum Hypertens. 1997;11:727-732.
4. Kannel WB, Neaton JD, Wentworth D, Thomas HE, Stamler J, Hulley SB, Kjelsberg MO. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Am Heart J. 1986;112:825-836.
5. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, Natali A, Ferrannini E, Campese VM. Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension. 1994;23:681-687.
6. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994;344:14-18.
7. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, Ruello N, Tomolillo C, Castello C, Grillo G, Sacchi G, Deferrari G. Prevalence and clinical correlates of microalbuminuria in essential hypertension: The Magic Study. Hypertension. 1997;30:1135-1143.
8. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
9. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995;44:1303-1309.
10. Deckert T, Yokoyama H, Mathiesen E, Rønn B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ. 1996;312:871-874.
11. Rossing P, Hougaard P, Borch-Johnsen K, Parving H-H. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ. 1996;313:779-784.
12. Borch-Johnsen B, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol. 1999;19:1992-1997.
13. Jørgensen T. Prevalence of gallstones in a Danish Population. Am J Epidemiol. 1987;126:912-921.
14. Schroll M. The World Health Organization MONICA Project: a major international collaboration. J Clin Epidemiol. 1988;41:105-114.
15. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. The Copenhagen City Heart Study Group. Urinary albumin excretion in a population based sample of 1,011 middle aged non-diabetic subjects. Scand J Clin Lab Invest. 1993;53:867-872.
16. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis. 1995;112:245-252.
17. Jensen JS, Myrup B, Borch-Johnsen K, Jensen G, Jensen T, Feldt-Rasmussen B. Aspects of haemostatic function in healthy subjects with microalbuminuria: a potential atherosclerotic risk factor. Thromb Res. 1995;77:423-430.
18. Jensen JS, Borch-Johnsen K, Deckert T, Deckert M, Jensen G, Feldt-Rasmussen B. Reduced glomerular size- and charge-selectivity in clinically healthy individuals with microalbuminuria. Eur J Clin Invest. 1995;25:608-614.
19. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci. 1995;88:629-633.
20. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Insulin sensitivity in clinically healthy individuals with microalbuminuria. Atherosclerosis. 1996;119:69-76.
21. Jensen JS, Borch-Johnsen K, Feldt-Rasmussen B, Appleyard M, Jensen G. Urinary albumin excretion and history of acute myocardial infarction in a cross-sectional population study of 2,613 individuals. J Cardiovasc Risk. 1997;4:121-125.
22. Clausen P, Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Ambulatory blood pressure and urinary albumin excretion in clinically healthy subjects. Hypertension. 1998;32:71-77.
23. Mogensen CE. Frontiers in medicine: systemic blood pressure and glomerular leakage with particular reference to diabetes and hypertension. J Intern Med. 1994;235:297-316.
24. th Revision. Geneva, Switzerland: World Health Organization; 1967.
25. Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant. 1997;12(suppl 2):6-9.
26. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest. 1985;45:539-544.
27. Larsen K. Creatinine assay by a reaction rate kinetic principle. Clin Chim Acta. 1972;45:209-217.
28. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;i:1430-1432.
29. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med. 1984;310:356-360.
30. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1986;9:85-95.
31. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP. Associations of urinary albumin excretion rate with vascular disease in Europid nondiabetic subjects. J Diabetes Complications. 1994;8:180-188.
32. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens. 1998;16:1325-1333.
33. Jager A, Kostense PJ, Ruhé HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CDA. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19:617-624.
34. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus. J Hypertens. 1995;13:463-469.
35. Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens. 1995;9:827-833.
36. Mykkänen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in non-diabetic and NIDDM subjects: the Insulin Resistance Atherosclerosis Study. Stroke. 1997;28:1710-1716.
37. O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK, Bommer W, Price TR, Gardin JM, Savage PJ. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group. Stroke. 1992;23:1752-1760.
38. Celermajer DS, Sørensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
39. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia. 1986;29:282-286.
40. Nørgaard K, Jensen T, Feldt-Rasmussen B. Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:57-61.
41. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1324-1329.
42. Pedrinelli R, Penno G, Dell'Omo G, Bandinelli S, Giorgi D, Di Bello V, Nannipieri M, Navalesi S, Mariani M. Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men. Hypertension. 1998;32:318-323.
43. van den Born J, van Kraats AA, Hill S, Bakker MA, Berden JH. Vessel wall heparan sulfate and transcapillary passage of albumin in experimental diabetes in the rat. Nephrol Dial Transplant. 1997; 12(suppl 2):27-31.0.
44. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno Hypothesis. Diabetologia. 1989;32:219-226.
45. Myrup B, Hansen PM, Jensen T, Kofoed-Enevoldsen A, Feldt-Rasmusen B, Gram J, Kluft C, Jespersen J, Deckert T. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet. 1995;345:421-422.
46. Yokoyama H, Høyer PE, Hansen PM, van den Born J, Jensen T, Berden JHM, Deckert T, Garharsch C. Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes. 1997;46:1875-1880.
47. Slender S, Zilversmilh DB. Transfer of plasma lipoprotein components and of plasma proteins into aortas of choleslerol-fed rabbits. Arteriosclerosis. 1981;1:38-49.
48. Slender S, Hjelms E. In vivo transfer of cholesterol from plasma into human aortic tissue. Scand J Clin Lab Invest. 1987;186(suppl):21-29.
49. Nordestgaard BG, Stender S, Kjeldsen K. Reduced atherogenesis in cholesterol-fed diabetic rabbits: giant lipoproteins do not enter the arterial wall. Arteriosclerosis. 1988;8:421-428.
50. 125I-LDL, and parenteral Evans blue dye protein complex along the aortas of normocholesterolemic minipigs as predictors of subsequent hypercholesterolemic atherogenesis. Arterioscler Thromb. 1993;13:1193-1204.
51. West JNW, Gosling P, Dimmitt SB, Littler WA. Non-diabetic microalbuminuria in clinical practice and its relationship to posture, exercise and blood pressure. Clin Sci. 1991;81:373-377.
52. Rodriguex BL, Curb D, Burchfiel CM, Abbott RD, Petrovitch H, Masaki K, Chiu D. Physical activity and 23-year incidence of coronary heart disease morbidity and mortality among middle-aged men: the Honolulu Heart Program. Circulation. 1994;89:2540-2544.
53. Jensen JS. Intra-individual variation of overnight urinary albumin excretion in clinically healthy middle aged individuals. Clin Chim Acta. 1995;243:95-99.
54. Jensen JS. The distribution of urinary albumin excretion and its association to atherosclerotic risk factors: a cross-sectional study of 2,613 individuals. Dan Med Bull. 1996;43:379-380. PhD thesis.